However, patients with T2DM were characterized by less difference in concentration of CNDP1 compare to GDM (Table 3), assumingly, due to activation of compensatory mechanisms engaging transport proteins (AFM, FBLN1 and APOM) for controlling the blood glucose levels [46,47,48]. This evidence concerns the gene AFM and type 2 diabetes mellitus.